Skip to main content
User account menu
Log in
X
Main navigation
About
Leadership
Advisory Board
News & Announcements
Messages from Our Leaders and Colleagues
Press Releases
HIV in the News
Events & Training
Grants & Funding
People
Email Groups
Publications
Requests for Manuscripts
Resources
Search
Home
News & Announcements
HIV / AIDS in the News
Opportunities for Low-Barrier HIV Testing in the U.S. Deep South: Findings from a Survey in Alabama - springermedicine.com
Thursday, November 13 2025 - 22:22
HCV core antigen testing accurately detects acute HCV in patients with HIV - European AIDS Treatment Group
Thursday, November 13 2025 - 20:11
HIV Pre-Exposure Prophylaxis Service Cascade and Risk Factors Associated with Loss to Follow-Up Among Key Populations in Indonesia: Data from a Real-World Pilot Implementation 2021–2023 - springermedicine.com
Thursday, November 13 2025 - 19:56
Iron supplement absorption preserved in children with HIV and boosted by prebiotics - European AIDS Treatment Group
Thursday, November 13 2025 - 19:36
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV-1 treatment meets primary endpoint in Phase 3 ARTISTRY-1 trial - European AIDS Treatment Group
Thursday, November 13 2025 - 19:16
Highlights from The Liver Meeting 2025 - European AIDS Treatment Group
Thursday, November 13 2025 - 18:41
Vanderbilt Institute for Global Health marks 20 years - VUMC News
Thursday, November 13 2025 - 16:43
History of the AIDS Crisis: A Timeline - Britannica
Thursday, November 13 2025 - 14:47
In under a year, Trump administration has threatened decades of progress in global fight against HIV/AIDS - prismreports.org
Thursday, November 13 2025 - 14:24
Unsuspected drug shortage is impacting the German HIV PrEP supply - results of a cross-sectional survey show: majority of PrEP users had to stop or switch to on-demand PrEP and higher unmet PrEP demand among women, diverse individuals, and those in - BMC…
Thursday, November 13 2025 - 14:14
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial - Gilead Sciences (NASDAQ:GILD) - Benzinga
Thursday, November 13 2025 - 13:55
Gilead stock rises after positive HIV treatment trial results - Investing.com
Thursday, November 13 2025 - 13:34
Watch ‘Still Here,’ A Short Documentary About HIV And Aging - inmagazine.ca
Thursday, November 13 2025 - 13:19
Gilead Sciences’ Strategic Advancements in HIV Treatment Bolster Buy Rating and Future Revenue Prospects - TipRanks
Thursday, November 13 2025 - 12:58
Maui AIDS Foundation to host Transgender Day of Remembrance and World AIDS Day - Maui Now
Thursday, November 13 2025 - 12:00
Accused rapist wanted to give men HIV, court hears - Yahoo News New Zealand
Thursday, November 13 2025 - 11:55
Accused Washington rapist meant to give men HIV, court hears - BBC
Thursday, November 13 2025 - 11:55
Accused Washington rapist meant to give men HIV, court hears - BBC
Thursday, November 13 2025 - 11:55
Gilead hits late-stage trial win for new single-tablet HIV therapy - Seeking Alpha
Thursday, November 13 2025 - 11:51
Gilead hits late-stage trial win for new HIV therapy (GILD) - Seeking Alpha
Thursday, November 13 2025 - 11:51
Single Tablet HIV Combination Therapy Demonstrates Noninferiority When Switched From Multi-Tablet Regimens - Contagion Live
Thursday, November 13 2025 - 11:09
Atlanta mourns the loss of HIV activist Dr. Alvan Quamina - Rough Draft Atlanta
Thursday, November 13 2025 - 9:56
Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings - Fierce Pharma
Thursday, November 13 2025 - 9:55
Gilead (GILD) Reveals Promising Phase 3 Trial Results for HIV Tr - GuruFocus
Thursday, November 13 2025 - 9:36
Gilead Reports Positive Phase 3 Results For Bictegravir/ Lenacapavir Single-tablet Regimen For HIV - Nasdaq
Thursday, November 13 2025 - 8:58
Monroe man accused of intentionally exposing others to HIV - hannapub.com
Thursday, November 13 2025 - 8:56
Gilead says single-tablet option matches complex HIV regimens in Phase III study - FirstWord Pharma
Thursday, November 13 2025 - 8:31
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial - Yahoo Finance
Thursday, November 13 2025 - 8:30
Iron Absorption and Supplementation in HIV-Positive Children - Bioengineer.org
Thursday, November 13 2025 - 7:42
Anal cancer, HIV, gay men, what you need to know - Q Voice News
Thursday, November 13 2025 - 4:50
Pagination
First page
« First
Previous page
‹‹
…
Page
29
Page
30
Page
31
Page
32
Current page
33
Page
34
Page
35
Page
36
Page
37
…
Next page
››
Last page
Last »